Bedford Laboratories has voluntarily recalled a single lot of its ‘Vecuronium Bromide for injection’ product due to “particulate matter,” according to an FDA news release.
Read the full report in Becker’s ASC Review on the voluntary recall.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
